The importance of understanding patient and physician preferences for psoriasis treatment characteristics: a systematic review of discrete-choice experiments

References

• Parisi R, Symmons DP, Griffiths CE, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–385.
   PubMed Web of Science ®Google Scholar
• Griffiths CEM, van der Walt JM, Ashcroft DM, et al. The global state of psoriasis disease epidemiology: a workshop report. Br J Dermatol. 2017;177(1):e4–e7.
   PubMed Web of Science ®Google Scholar
• Bhosle MJ, Kulkarni A, Feldman SR, et al. Quality of life in patients with psoriasis. Health Qual Life Outcomes. 2006;4:35.
   PubMed Web of Science ®Google Scholar
• de Arruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br. J. Dermatol. 2001;144(Suppl 58):33–36.
   PubMed Web of Science ®Google Scholar
• Umar N, Schaarschmidt M, Schmieder A, et al. Matching physicians’ treatment recommendations to patients’ treatment preferences is associated with improvement in treatment satisfaction. J Eur Acad Dermatol Venereol. 2013;27(6):763–770.
   PubMed Web of Science ®Google Scholar
• Thorneloe RJ, Bundy C, Griffiths CE, et al. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis. Br J Dermatol. 2017;176(3):667–676.
   PubMed Web of Science ®Google Scholar
• Jevtic T, Bukumiric Z, Jankovic SM. Effects of treatment adherence on clinical and economic outcomes in patients with psoriasis. Med Glas (Zenica). 2013;10(1):106–112.
   PubMedGoogle Scholar
• Kitchen H, Cordingley L, Young H, et al. Patient-reported outcome measures in psoriasis: the good, the bad and the missing!. Br J Dermatol. 2015;172(5):1210–1221.
   PubMed Web of Science ®Google Scholar
• Florek AG, Wang CJ, Armstrong AW. Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review. Arch Dermatol Res. 2018;310(4):271–319.
   PubMed Web of Science ®Google Scholar
• Bridges J, Onukwugha E, Johnson F, et al. Patient preference methods—a patient centered evaluation paradigm. ISPOR Connections. 2007;13(6):4–7.
   Google Scholar
• Bolt T, Mahlich J, Nakamura Y, et al. Hematologists’ preferences for first-line therapy characteristics for multiple myeloma in Japan: attribute rating and discrete choice experiment . Clin Ther. 2018;40(2):296–308.e2.
   PubMed Web of Science ®Google Scholar
• Ho MP, Gonzalez JM, Lerner HP, et al. Incorporating patient-preference evidence into regulatory decision making. Surg Endosc. 2015;29(10):2984–2993.
   PubMed Web of Science ®Google Scholar
• Underwood G. NICE to research patient preferences in HTA. 2016; [cited 2020 Jun 2]. Available from: http://www.pharmatimes.com/news/nice_to_research_patient_preferences_in_hta_1033029.
   Google Scholar
• van Overbeeke E, Whichello C, Janssens R, et al. Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review. Drug Discov Today. 2019;24(1):57–68.
   PubMed Web of Science ®Google Scholar
• Mangham LJ, Hanson K, McPake B. How to do (or not to do). Designing a discrete choice experiment for application in a low-income country. Health Policy Plan. 2009;24(2):151–158.
   PubMed Web of Science ®Google Scholar
• Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ. 2000;320(7248):1530–1533.
   PubMed Web of Science ®Google Scholar
• Alcusky M, Lee S, Lau G, et al. Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis. Dermatol Ther (Heidelb). 2017;7(4):463–483.
   PubMed Web of Science ®Google Scholar
• Reed SD, Lavezzari G. International experiences in quantitative benefit-risk analysis to support regulatory decisions. Value Health. 2016;19(6):727–729.
   PubMed Web of Science ®Google Scholar
• Vass CM, Payne K. Using discrete choice experiments to inform the benefit-risk assessment of medicines: are we ready yet? Pharmacoeconomics. 2017;35(9):859–866.
   PubMed Web of Science ®Google Scholar
• Schaarschmidt M-L, Schmieder A, Umar N, et al. Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes. Arch Dermatol. 2011;147(11):1285–1294.
   PubMedGoogle Scholar
• Kauf TL, Yang J-C, Kimball AB, et al. Psoriasis patients’ willingness to accept side-effect risks for improved treatment efficacy. J Dermatolog Treat. 2015;26(6):507–513.
   PubMed Web of Science ®Google Scholar
• Schaarschmidt M-L, Kromer C, Herr R, et al. Patient preferences for biologicals in psoriasis: top priority of safety for cardiovascular patients. PLoS One. 2015;10(12):e0144335.
   PubMed Web of Science ®Google Scholar
• Gonzalez JM. Evaluating risk tolerance from a systematic review of preferences: the case of patients with psoriasis. The patient-patient-centered outcomes research. Patient. 2018;11(3):285–300.
   PubMedGoogle Scholar
• Fink A. Conducting research literature reviews: from the Internet to paper. Los Angeles: Sage Publications; 2019.
   Google Scholar
• Yu T, Enkh-Amgalan N, Zorigt G. Methods to perform systematic reviews of patient preferences: a literature survey. BMC Med Res Methodol. 2017;17(1):166.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
   PubMed Web of Science ®Google Scholar
• Umar N, Yamamoto S, Loerbroks A, et al. Elicitation and use of patients’ preferences in the treatment of psoriasis: a systematic review. Acta Derm Venereol. 2012;92(4):341–347.
   PubMed Web of Science ®Google Scholar
• Kleij K-S, Tangermann U, Amelung VE, et al. Patients’ preferences for primary health care – a systematic literature review of discrete choice experiments. BMC Health Serv Res. 2017;17(1):476.
   PubMed Web of Science ®Google Scholar
• Papaioannou D, Sutton A, Carroll C, et al. Literature searching for social science systematic reviews: consideration of a range of search techniques. Health Info Libr J. 2010;27(2):114–122.
   PubMed Web of Science ®Google Scholar
• Cuchacovich R, Perez-Alamino R, Garcia-Valladares I, et al. Steps in the management of psoriatic arthritis: a guide for clinicians. Ther Adv Chronic Dis. 2012;3(6):259–269.
   PubMedGoogle Scholar
• Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health-a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011;14(4):403–413.
   PubMed Web of Science ®Google Scholar
• Reed Johnson F, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3–13.
   PubMed Web of Science ®Google Scholar
• Joy SM, Little E, Maruthur NM, et al. Patient preferences for the treatment of type 2 diabetes: a scoping review. Pharmacoeconomics. 2013;31(10):877–892.
   PubMed Web of Science ®Google Scholar
• Hauber AB, González JM, Groothuis-Oudshoorn CG, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force. Value Health. 2016;19(4):300–315.
   PubMed Web of Science ®Google Scholar
• Kromer C, Schaarschmidt M-L, Schmieder A, et al. Patient preferences for treatment of psoriasis with biologicals: a discrete choice experiment. PLoS One. 2015;10(6):e0129120.
   PubMed Web of Science ®Google Scholar
• Rothery C, Bojke L, Richardson G, et al. A discrete choice experiment to explore patients’ willingness to risk disease relapse from treatment withdrawal in psoriatic arthritis. Clin Rheumatol. 2016;35(12):2967–2974.
   PubMed Web of Science ®Google Scholar
• Eliasson L, Bewley AP, Mughal F, et al. Evaluation of psoriasis patients’ attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments . Patient Prefer Adherence. 2017;11:353–362.
   PubMed Web of Science ®Google Scholar
• Fairchild AO, Reed SD, Johnson FR, et al. What is clearance worth? Patients’ stated risk tolerance for psoriasis treatments. J Dermatolog Treat. 2017;28(8):709–715.
   PubMed Web of Science ®Google Scholar
• Guevara B, Gonzales N, Visitacion L. patient preference on psoriasis treatment in a Philippine Tertiary Hospital: a conjoint analysis: P127. J Eur Acad Dermatol Venereol. 2017;30:62.
   Google Scholar
• Gonzalez J, Johnson F, McAteer H, et al. Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment. Br J Dermatol. 2017;176(3):777–785.
   PubMed Web of Science ®Google Scholar
• Bolt T, Kobayashi H, Mahlich J. Patient and physician preferences for therapy characteristics for psoriasis: a discrete choice experiment in Japan. PharmacoEconomics-open. 2018;3:255–264.
   Web of Science ®Google Scholar
• Schaarschmidt M-L, Herr R, Gutknecht M, et al. Patients’ and physicians’ preferences for systemic psoriasis treatments: a nationwide comparative discrete choice experiment (PsoCompare). Acta Derm Venereol. 2018;98(2):200–205.
   PubMed Web of Science ®Google Scholar
• Xu Y, Sudharshan L, Hsu M-A, et al. Patient preferences associated with therapies for psoriatic arthritis: a conjoint analysis. Am Health Drug Benefits. 2018;11(8):408.
   PubMed Web of Science ®Google Scholar
• Feldman SR, Regnier SA, Chirilov A, et al. Patient-reported outcomes are important elements of psoriasis treatment decision making: a discrete choice experiment survey of dermatologists in the United States. J Am Acad Dermatol. 2019;80(6):1650–1657.
   PubMed Web of Science ®Google Scholar
• Tada Y, Ishii K, Kimura J, et al. Patient preference for biologic treatments of psoriasis in Japan. J Dermatol. 2019;46(6):466–477.
   PubMed Web of Science ®Google Scholar
• Ashcroft D, Seston E, Griffiths C. Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists. Br J Dermatol. 2006;155(6):1236–1241.
   PubMed Web of Science ®Google Scholar
• Seston EM, Ashcroft DM, Griffiths CE. Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis. Arch Dermatol. 2007;143(9):1175–1179.
   PubMedGoogle Scholar
• Hauber AB, Gonzalez JM, Schenkel B, et al. The value to patients of reducing lesion severity in plaque psoriasis. J Dermatolog Treat. 2011;22(5):266–275.
   PubMed Web of Science ®Google Scholar
• Schmieder A, Schaarschmidt M-L, Umar N, et al. Comorbidities significantly impact patients’ preferences for psoriasis treatments. J Am Acad Dermatol. 2012;67(3):363–372.
   PubMed Web of Science ®Google Scholar
• Umar N, Schöllgen I, Terris DD. It is not always about gains: utilities and disutilities associated with treatment features in patients with moderate-to-severe psoriasis. Patient Preference and Adherence. 2012;6:187.
   PubMed Web of Science ®Google Scholar
• Schaarschmidt ML, Umar N, Schmieder A, et al. Patient preferences for psoriasis treatments: impact of treatment experience. J Eur Acad Dermatol Venereol. 2013;27(2):187–198.
   PubMed Web of Science ®Google Scholar
• Torbica A, Fattore G, Ayala F. Eliciting preferences to inform patient-centred policies: the case of psoriasis. Pharmacoeconomics. 2014;32(2):209–223.
   PubMed Web of Science ®Google Scholar
• Kromer C, Peitsch WK, Herr R, et al. Treatment preferences for biologicals in psoriasis: experienced patients appreciate sustainability. J Dtsch Dermatol Ges. 2017;15(2):189–200.
   Web of Science ®Google Scholar
• Rigopoulos D, Ioannides D, Chaidemenos G, et al. Patient preference study for different characteristics of systemic psoriasis treatments (Protimisis). Dermatol Ther. 2018;31(3):e12592
   PubMed Web of Science ®Google Scholar
• The World Bank. World Bank Country and Lending Groups. 2019.
   Google Scholar
• Bien DR, Danner M, Vennedey V, et al. Patients’ preferences for outcome, process and cost attributes in cancer treatment: a systematic review of discrete choice experiments. Patient. 2017;10(5):553–565.
   PubMedGoogle Scholar
• National Institute for Health and Care Excellence. NICE provides first scientific advice on patient preference study design. 2019; [cited 2020 Jun 2]. Available from: https://www.nice.org.uk/news/article/nice-provides-first-scientific-advice-on-patient-preference-study-design.
   Google Scholar
• Johnson FR, Zhou M. Patient preferences in regulatory benefit-risk assessments: a US perspective. Value Health. 2016;19(6):741–745.
   PubMed Web of Science ®Google Scholar
• Klein AV, Hardy S, Lim R, et al. Regulatory decision making in Canada-exploring new frontiers in patient involvement. Value Health. 2016;19(6):730–733.
   PubMed Web of Science ®Google Scholar
• Mott DJ. Incorporating quantitative patient preference data into healthcare decision making processes: is hta falling behind? Singapore: Springer; 2018.
   Google Scholar
• Mühlbacher AC, Juhnke C, Beyer AR, et al. Patient-focused benefit-risk analysis to inform regulatory decisions: the European Union perspective. Value Health. 2016;19(6):734–740.
   PubMed Web of Science ®Google Scholar
• Addelman S. Symmetrical and asymmetrical fractional factorial plans. Technometrics. 1962;4(1):47–58.
   Web of Science ®Google Scholar
• Puig L. PASI90 response: the new standard in therapeutic efficacy for psoriasis. J Eur Acad Dermatol Venereol. 2015;29(4):645–648.
   PubMed Web of Science ®Google Scholar
• Mühlbacher AC, Juhnke C. Patient preferences versus physicians’ judgement: does it make a difference in healthcare decision making? Appl Health Econ Health Policy. 2013;11(3):163–180.
   PubMedGoogle Scholar
• Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566–577.
   PubMed Web of Science ®Google Scholar
• Stacey D, Légaré F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews. 2017;4(4):CD001431.
   PubMed Web of Science ®Google Scholar